Revista Portuguesa de Cardiologia
短名 | Rev. Port. Cardiol. (Engl. Ed). |
Journal Impact | 1.51 |
国际分区 | CARDIAC & CARDIOVASCULAR SYSTEMS(Q3) |
期刊索引 | SCI Q4中科院 4 区 |
ISSN | 0870-2551, 2174-2030 |
h-index | 30 |
国内分区 | 医学(4区)医学心脏和心血管系统(4区) |
葡萄牙心脏病学杂志是葡萄牙心脏病学会的官方期刊,成立于 1982 年,旨在通过发表有关心律失常和电生理学、心血管外科、重症监护、冠状动脉等领域的科学文章,让葡萄牙心脏病学家了解最新情况疾病、心血管影像学、高血压、心力衰竭和心血管预防。该杂志是月刊,在科学内容和生产方面具有高质量标准。自 1999 年以来,它以英语和葡萄牙语出版,扩大了海外读者群。它分发给葡萄牙心脏病学会、内科学会、肺病学会和心胸外科学会的所有成员,以及领先的非葡萄牙心脏病专家和全球几乎所有心脏病学会。自 1987 年以来,它已在 MEDLINE 中提及。
期刊主页投稿网址涉及主题 | 医学内科学心脏病学生物外科心理学放射科精神科病理内分泌学心肌梗塞 |
出版信息 | 出版商: Sociedade Portuguesa de Cardiologia,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 1982,原创研究文献占比: 86.36%,自引率:12.50%, Gold OA占比: 98.82% |
平均审稿周期 | 网友分享经验:偏慢,4-8周 |
平均录用比例 | 网友分享经验:容易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Knowledge and perception among adults of their congenital heart disease: A single center cross-sectional study
2024-9-1
Clinical features and long-term outcomes in patients under 35 years with coronary artery disease: nested case-control study
2024-9-1
Of mice and man
2024-9-1
Not an allergy: Iodine contrast-induced acute sialadenitis after coronary angiography
2024-8-1
Regional myocardial infarction networks: How to improve quality
2024-8-1
Real-world evaluation of vascular complications and comorbidities in Portuguese patients with Type 2 Diabetes: Results from the cMORE study
2024-8-1
Atrial fibrillation ablation in patients with heart failure: Which patients are most likely to respond?
2024-8-1
One more piece for the puzzle of stem cell therapy in cardiovascular diseases
2024-8-1
Investigation of the effect of intravitreal bevacizumab treatment on left heart function using speckle tracking echocardiography
2024-8-1
Left ventricular global longitudinal strain is associated with filling pressures and cardiac output in an outpatient setting: Insights from the CardioMEMSTM
2024-8-1
Diagnostic prediction rules in acute pulmonary embolism: Is it acceptable to compromise safety?
2024-8-1
Cardioprotective effect of chelidonic acid against doxorubicin-induced cardiac toxicity in rats
2024-8-1
Importance and usefulness of SCORE2 in Cardiovascular Prevention
2024-8-1
Sex-related differences in ST-segment elevation myocardial infarction: A Portuguese multicenter national registry analysis
2024-8-1
Dapagliflozin: Improving heart failure outcomes does not necessarily mean increasing costs
2024-8-1
Cardiac arrest: It is important not just to survive, but to survive with at least an acceptable quality of life
2024-8-1
Response to the letter “Cardio-oncology guidelines, structural heart disease and Kounis syndrome in the upcoming guidelines”
2024-7-1
Real-world evaluation of vascular complications and comorbidities in Portuguese patients with type 2 diabetes: Results from the cMORE study
2024-7-1
Exploring the evidence gap: Loop diuretic withdrawal in chronic heart failure
2024-7-1
The association between pre-existing heart failure and cancer incidence: A systematic review and meta-analysis
2024-7-1
Customizing solutions: Ventricular tachycardia and implantable cardioverter-defibrillator programming
2024-7-1
Rare images of a unileaflet mitral valve
2024-7-1
Moderately intense physical exercise alleviates electrocardiographic changes induced by cisplatin in rats
2024-7-1
Early versus late cardiac magnetic resonance in the diagnosis of MINOCA
2024-7-1
Cardiac rehabilitation training in cardiology residency: A missing block in the training program
2024-7-1
The balance between thrombosis and bleeding after mitral valve surgery: The need for robust evidence
2024-7-1
Exercise and Sports revisited: is too much exercise bad for your heart?
2024-7-1
“Observe, simulate, execute and mentor”: a contemporary approach to learning in Interventional Cardiology
2024-7-1
Left atrial appendage thrombus in severe mitral stenosis: Can chamber morphology and thrombus location influence therapeutic choice?
2024-7-1
Initial experience with orbital atherectomy in a non-surgical center in Portugal
2024-7-1
Cardiovascular risk assessment using SCORE2 in a population with hypertension - the reality at a primary health care unit
2024-7-1
Beyond Clinical Trials – The cost-saving associated with dapagliflozin use in portuguese hospital clinical practice
2024-7-1
Heart with Mozambique: A Portuguese contribution to the eradication of rheumatic heart disease
2024-7-1
Enhancing diagnostic yield in MINOCA: The Critical Timing of Cardiac magnetic resonance
2024-7-1
Pulmonary arterial hypertension: Navigating the pathways of progress in diagnosis, treatment, and patient care
2024-7-1
World Heart Federation Cholesterol Roadmap: The Portuguese case
2024-7-1
Mesenchymal stem cells may alleviate angiotensin II-induced myocardial fibrosis and hypertrophy by upregulating SFRS3 expression
2024-7-1
Is the cardiovascular risk SCORE2 globally valid and useful?
2024-6-1
Response to the letter “Cardio-oncology guidelines, structural heart disease and Kounis syndrome in the upcoming guidelines”
2024-6-1
Chronic thromboembolic pulmonary hypertension: A comprehensive review of pathogenesis, diagnosis, and treatment strategies
2024-6-1
“O meu coração bate saudável” – Results from a pilot project for health education in Portuguese children
2024-6-1
“The challenge of choosing the right prosthesis for the right patient - The devil is in the details”
2024-6-1
Non-vitamin K versus vitamin K antagonist oral anticoagulants in surgical mitral valve repair or bioprosthetic valve replacement in the first three months after surgery
2024-6-1
Polytetrafluoroethylene graft for anomalous left coronary artery from the pulmonary artery: 6-year patency
2024-6-1
Loop diuretic discontinuation in chronic heart failure patients: A retrospective study
2024-6-1
Tuberculous submitral aneurysm: A rare cardiac presentation of a common pathogen
2024-6-1
Cardiac hydatid cysts: Please do not waste time
2024-6-1
Outcomes of ventricular tachycardia ablation in patients with ischemic and non-ischemic cardiomyopathy: A propensity score matched analysis
2024-6-1
Idiopathic ventricular fibrillation: A never ending “clinical” history
2024-5-31
Ventricular tachycardia ablation in non-ischemic cardiomyopathy: A Sisyphean task?
2024-5-31
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远